Iandra Luah Souza Maia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Iandra Luah Souza Maia has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Rosany Larissa Brito de Oliveira
Federal University of Sergipe
3 shared publications - Álvaro Bezerra Cardoso
Federal University of Sergipe
3 shared publications - Antônio Carlos Marqueti
Universidade Federal de Sergipe, Brasil
2 shared publications - Paula Patrícia Santos Santos
Universidade Federal de Sergipe, Brasil
2 shared publications - Ellen Maiany Ribeiro Santana
Universidade Federal de Sergipe, Brasil
1 shared publication - Geydson Silveira da Cruz
Federal University of Sergipe
1 shared publication
Latest Publications
- Open Access
- 18 July 2025
- Published by Universidade Estadual de Campinas in Brazilian Journal of Oral Sciences
- Vol. 24, e257209
Oral manifestations in patients undergoing chemotherapy
The proposed treatment for malignant neoplasms can be isolated or combined, involving resective surgery, radiotherapy, chemotherapy, and/or hormone replacement. Chemotherapy induces extensive immunosuppression and affects both healthy and abnormal cells. This cytotoxicity from the treatment has a significant effect that can lead to changes in the oral mucosa. The severity is related to the type of drug, duration of treatment, dosage used, level of oral hygiene during treatment, and the individual’s age. Therefore, monitoring oral health before, during, and after antineoplastic therapy is essential. Aim: To evaluate the main oral manifestations that oncology patients presented before and after 15 days from the first administration of chemotherapy medication. Methods: A prospective observational study was conducted with 31 individuals treated at a Hospital Oncology and Hematology Service. The evaluations included the following steps: (1) Patient identification and completion of assessment forms; (2) Clinical examination of the oral cavity before and after the start of chemotherapy; and (3) Providing guidance to patients regarding oral care during oncological treatment. Results: It was observed that 70.96% of patients exhibited oral manifestations 15 days after the first infusion of antineoplastic drugs. The main changes identified included xerostomia and oral mucositis. Conclusion: Dental follow-up during chemotherapy is essential for preventing and managing potential oral emergencies, thereby avoiding interruptions in systemic treatment and ultimately enhancing the quality of life for these patients.
- 18 July 2025
- Published by Universidade Estadual de Campinas in Brazilian Journal of Oral Sciences
- Vol. 24, e257209
Open AccessOral manifestations in patients undergoing chemotherapy
The proposed treatment for malignant neoplasms can be isolated or combined, involving resective surgery, radiotherapy, chemotherapy, and/or hormone replacement. Chemotherapy induces extensive immunosuppression and affects both healthy and abnormal cells. This cytotoxicity from the treatment has a significant effect that can lead to changes in the oral mucosa. The severity is related to the type of drug, duration of treatment, dosage used, level of oral hygiene during treatment, and the individual’s age. Therefore, monitoring oral health before, during, and after antineoplastic therapy is essential. Aim: To evaluate the main oral manifestations that oncology patients presented before and after 15 days from the first administration of chemotherapy medication. Methods: A prospective observational study was conducted with 31 individuals treated at a Hospital Oncology and Hematology Service. The evaluations included the following steps: (1) Patient identification and completion of assessment forms; (2) Clinical examination of the oral cavity before and after the start of chemotherapy; and (3) Providing guidance to patients regarding oral care during oncological treatment. Results: It was observed that 70.96% of patients exhibited oral manifestations 15 days after the first infusion of antineoplastic drugs. The main changes identified included xerostomia and oral mucositis. Conclusion: Dental follow-up during chemotherapy is essential for preventing and managing potential oral emergencies, thereby avoiding interruptions in systemic treatment and ultimately enhancing the quality of life for these patients.
- Open Access
- 1 August 2024
- Published by Research, Society and Development in Research, Society and Development
- Vol. 13 (8)
Efeito do raspador lingual de polietilenotereftalato na remoção da saburra lingual
O objetivo deste trabalho foi comparar um raspador de língua obtido de garrafas de polietilenotereftalato (PET) com um modelo comercial (COM). Um desenho paralelo, controlado e randomizado foi usado. Dos 61 voluntários do Departamento de Odontologia da Universidade Federal de Sergipe, 30 atenderam aos critérios de inclusão e exclusão para distribuição aleatória em 2 grupos: PET (n=15) e COM (n=15). Na consulta inicial, o Índice de Saburra Lingual de Winkel (ISL-W) foi medido antes (T0) e imediatamente após (T1) remoção da saburra lingual realizada pelo profissional, que forneceu instruções para uso caseiro do raspador 2 vezes ao dia. Após 14 dias, o ISL-W foi mensurado em T0 e T1, com remoção da saburra feita pelo participante. Dos 30, 1 do grupo COM não retornou para consulta de 14 dias. Os dados obtidos em T0 e T1 foram submetidos ao teste t-Student pareado (α=0,05). As diferenças entre T0 e T1 foram transformadas em valores percentuais e analisadas com teste t de Student não pareado (α=0,05). Os dados de T0 das consultas inicial e após 14 dias foram submetidos ao teste t-Student pareado (α=0,05). Os resultados indicaram que os 2 raspadores reduziram significantemente o ISL-W (P<0,05), com percentuais de redução semelhantes: PET (34±36%) e COM (32±22%); houve redução significante do ISL-W após 14 dias de uso caseiro dos raspadores de língua (P<0,01). Concluiu-se que o raspador de língua PET foi capaz de remover a saburra lingual, com resultados semelhantes ao COM, reduzindo o ISL-W após 14 dias de uso caseiro.
- 1 August 2024
- Published by Research, Society and Development in Research, Society and Development
- Vol. 13 (8)
Open AccessEfeito do raspador lingual de polietilenotereftalato na remoção da saburra lingual
O objetivo deste trabalho foi comparar um raspador de língua obtido de garrafas de polietilenotereftalato (PET) com um modelo comercial (COM). Um desenho paralelo, controlado e randomizado foi usado. Dos 61 voluntários do Departamento de Odontologia da Universidade Federal de Sergipe, 30 atenderam aos critérios de inclusão e exclusão para distribuição aleatória em 2 grupos: PET (n=15) e COM (n=15). Na consulta inicial, o Índice de Saburra Lingual de Winkel (ISL-W) foi medido antes (T0) e imediatamente após (T1) remoção da saburra lingual realizada pelo profissional, que forneceu instruções para uso caseiro do raspador 2 vezes ao dia. Após 14 dias, o ISL-W foi mensurado em T0 e T1, com remoção da saburra feita pelo participante. Dos 30, 1 do grupo COM não retornou para consulta de 14 dias. Os dados obtidos em T0 e T1 foram submetidos ao teste t-Student pareado (α=0,05). As diferenças entre T0 e T1 foram transformadas em valores percentuais e analisadas com teste t de Student não pareado (α=0,05). Os dados de T0 das consultas inicial e após 14 dias foram submetidos ao teste t-Student pareado (α=0,05). Os resultados indicaram que os 2 raspadores reduziram significantemente o ISL-W (P<0,05), com percentuais de redução semelhantes: PET (34±36%) e COM (32±22%); houve redução significante do ISL-W após 14 dias de uso caseiro dos raspadores de língua (P<0,01). Concluiu-se que o raspador de língua PET foi capaz de remover a saburra lingual, com resultados semelhantes ao COM, reduzindo o ISL-W após 14 dias de uso caseiro.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in RGO - Revista Gaúcha de Odontologia
- Vol. 72, e20240018
Pleomorphic adenoma treatment in a patient with neurodegenerative disease: case report
Pleomorphic adenoma (PA) is a benign tumor, responsible for more than 50% of the cases of salivary gland neoplasms, occurring both the major and minor salivary glands. In the oral cavity, the most frequent sites of pleomorphic adenoma are the palate and the lips, with greater preference for females and frequently affecting individuals in the fourth to fifth decade of life. The treatment of choice is based on total lesion excision with a good prognosis, which has a low potential for recurrence and malignant transformation. The objective of the study was reporting a treatment of pleomorphic adenoma localized in the hard palate of the 74-year-old male patient, F.A.S. with Parkinson’s disease. The patient is in outpatient follow-up for over a year with no signs of recurrence. Computed Tomography is an indispensable tool for directing the correct diagnosis, which is only definitive after the histopathological examination. The most indicated treatment with good prognosis is complete surgical excision of the lesion and curettage.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in RGO - Revista Gaúcha de Odontologia
- Vol. 72, e20240018
Open AccessPleomorphic adenoma treatment in a patient with neurodegenerative disease: case report
Pleomorphic adenoma (PA) is a benign tumor, responsible for more than 50% of the cases of salivary gland neoplasms, occurring both the major and minor salivary glands. In the oral cavity, the most frequent sites of pleomorphic adenoma are the palate and the lips, with greater preference for females and frequently affecting individuals in the fourth to fifth decade of life. The treatment of choice is based on total lesion excision with a good prognosis, which has a low potential for recurrence and malignant transformation. The objective of the study was reporting a treatment of pleomorphic adenoma localized in the hard palate of the 74-year-old male patient, F.A.S. with Parkinson’s disease. The patient is in outpatient follow-up for over a year with no signs of recurrence. Computed Tomography is an indispensable tool for directing the correct diagnosis, which is only definitive after the histopathological examination. The most indicated treatment with good prognosis is complete surgical excision of the lesion and curettage.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in RGO - Revista Gaúcha de Odontologia
- Vol. 71, e20230035
The importance of dental practice in oncological treatment: a case report associated with breast cancer
In Brazil, the estimated number of new cancer cases between 2020 and 2022 is 625 thousand, and the most prevalent carcinomas are primarily skin (non-melanoma), followed by those of the breast, prostate, colon, and rectum. Although breast carcinoma still has a high mortality rate, it has a good prognosis due to the increase in early diagnosis and the evolution of anticancer treatments. The proposed treatment can be isolated or associated with resective surgery, radiotherapy, chemotherapy, and/or hormone replacement. Chemotherapy generates extensive immunosuppression and affects both healthy and altered cells, and the cytotoxicity of the treatment is an important effect that can cause lesions on the oral mucosa. Severity is related to the type of chemotherapeutic agent, treatment time, the dose used, and the individual’s age. Additionally, chemotherapy treatment can exacerbate preexisting conditions in the individual and cause greater discomfort during treatment. Therefore, monitoring oral health before, during, and after anticancer therapy is essential. The objective of this work is to report a clinical case of dental emergency in a patient after the first cycle of doxorubicin- cyclophosphamide-paclitaxel (ACTdd) to treat breast cancer.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in RGO - Revista Gaúcha de Odontologia
- Vol. 71, e20230035
Open AccessThe importance of dental practice in oncological treatment: a case report associated with breast cancer
In Brazil, the estimated number of new cancer cases between 2020 and 2022 is 625 thousand, and the most prevalent carcinomas are primarily skin (non-melanoma), followed by those of the breast, prostate, colon, and rectum. Although breast carcinoma still has a high mortality rate, it has a good prognosis due to the increase in early diagnosis and the evolution of anticancer treatments. The proposed treatment can be isolated or associated with resective surgery, radiotherapy, chemotherapy, and/or hormone replacement. Chemotherapy generates extensive immunosuppression and affects both healthy and altered cells, and the cytotoxicity of the treatment is an important effect that can cause lesions on the oral mucosa. Severity is related to the type of chemotherapeutic agent, treatment time, the dose used, and the individual’s age. Additionally, chemotherapy treatment can exacerbate preexisting conditions in the individual and cause greater discomfort during treatment. Therefore, monitoring oral health before, during, and after anticancer therapy is essential. The objective of this work is to report a clinical case of dental emergency in a patient after the first cycle of doxorubicin- cyclophosphamide-paclitaxel (ACTdd) to treat breast cancer.